Vaginal flora: composition, function, disturbances and clinical significance

Composition and typical characteristics

In many healthy people the vaginal microbiota are dominated by species of Lactobacillus. These bacteria produce acids and other substances that maintain a relatively low vaginal pH and create conditions unfavorable to invasive organisms. However, there is natural variation between individuals and populations: some women have communities with a mix of anaerobic bacteria or other genera. The microbiota are a subset of the larger set of very small organisms that inhabit the human body and form mutually interacting ecosystems.

Major functions

• Barrier to pathogens: Normal flora help prevent colonization by harmful pathogens and can stop infections by outcompeting or inhibiting them.
• pH regulation: Acid production keeps the environment less hospitable to many microbes.
• Immune modulation: Resident microbes interact with local immune cells and can influence inflammatory responses.

These activities reduce the risk of symptomatic overgrowth and support mucosal integrity. Nonetheless, the presence of microorganisms is normal and not synonymous with disease.

Disturbances, common conditions and clinical signs

When the balance of the vaginal microbiota shifts, a condition called dysbiosis can develop. The most common example is bacterial vaginosis (BV), in which lactobacilli are reduced and mixed anaerobic bacteria increase; another frequent disorder is vulvovaginal candidiasis, caused by yeast overgrowth. Changes in the microbiota may follow antibiotic use, hormonal fluctuations, sexual activity, douching, or other exposures. A symptomatic imbalance often produces signs such as abnormal odor, irritation, or vaginal discharge. Sexually transmitted infections can alter the microbiota but are not prevented or cured by it; sexually activity can also change community structure (sexually transmitted infections are a separate category of illness).

Diagnosis, treatment and prevention

Clinicians assess suspected problems by history, examination and laboratory tests. Methods include microscopy, culture, molecular tests and scoring systems used for BV. Management targets the underlying disturbance: antibiotics (for example metronidazole) are commonly used for BV, antifungal agents for candidiasis, and specific therapy for sexually transmitted pathogens. Adjunctive strategies under study include probiotics and behaviors that preserve normal flora. Preventive advice typically discourages unnecessary antibiotics and vaginal douching and encourages safe sexual practices.

Notable facts and research directions

Research continues into how vaginal microbiota affect pregnancy outcomes, susceptibility to sexually transmitted infections, and long-term reproductive health. Microbial profiles vary with age, ethnicity, pregnancy and contraceptive use, and newborn colonization may be influenced by mode of delivery. Although many details are active areas of study, the central clinical message is consistent: a stable, lactobacillus-rich microbiota is associated with vaginal health, while disruption can increase symptoms and risk of complications.

For further reading and patient information see general resources on microbial biology and reproductive health: microorganisms, reproductive organs, and diagnostic approaches such as microscopy and molecular testing (microscope, stop infections). Additional context about related body sites and microbes can be found under topics like stomach microbiota and comparisons with the vagina. For organism-specific information see pages on Lactobacillus, common bacteria and fungi, and clinical concepts such as pathogens, vaginal discharge, and sexual health (sexually transmitted infections).